Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)

• Published in: Pharmaceutics Vol. 14; no. 12; p. 2598
• Main Authors: Souza, José Diogo R., Pacheco, Julia Cozar, Rossi, Giordano Novak, de-Paulo, Bruno O., Zuardi, Antonio W., Guimarães, Francisco S., Hallak, Jaime E. C., Crippa, José Alexandre, Dos Santos, Rafael G.
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 25.11.2022; MDPI
• Subjects: Adverse and side effects; adverse effects; Anesthesia; Anticonvulsants; Bias; Cannabidiol; CBD; Clinical trials; Convulsions & seizures; Drug dosages; drug interaction; Drug interactions; Drugs; Epilepsy; Evaluation; Marijuana; Pharmacology, Experimental; Psychosis; safety; Sleep; Statistical analysis; Substance abuse treatment; Systematic Review; Brazil; United Kingdom > UK; United States > US; cannabidiol; adverse effects; CBD; drug interaction; safety

(1) Background: With the massive demand for the use and commercialization of medicinal cannabidiol (CBD) products, new randomized clinical trials (RCTs) are being published worldwide, with a constant need for safety and efficacy evaluation. (2) Methods: We performed an update on a systematic review...